ArticleJournal for immunotherapy of cancer2019

Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells.

Wanfeng Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.